Patrick J. Farley


Patrick J. Farley is a partner in Montgomery McCracken’s Intellectual Property Department. He has over 20 years of international experience in intellectual property law and concentrates his practice on all aspects of intellectual property, including patent drafting, patent prosecution, patent litigation, patent and trademark portfolio management, and licensing.

Patrick counsels companies in the biotechnology and pharmaceuticals industries with a particular focus on patent and trademark portfolios, agreements, and due diligence.

Prior to joining Montgomery McCracken, Patrick was an attorney at a biotechnology company.

Patrick earned his J.D. degree, magna cum laude, from Temple University’s James E. Beasley School of Law, where he was President of the Intellectual Property Law Society, a member of Temple Law Review, and a recipient of the Technical Advisory Service for Attorneys price, Robert C. Podwil Memorial Prize, Jerry Zaslow Award, and the Isadore A. Shrager Scholarship. He received his Ph.D. from Hahnemann University, where he was the recipient of the Leslie Stauber Award and Amedeo Bondi Fellowship Award and a member of Sigma Xi Honor Society. Patrick earned his M.S. from the University of Pennsylvania, where he was a recipient of the Leslie Stauber Award, and his B.A. degree from Hamilton College, where he was on the Dean’s List, a recipient of the Renwick Prize, and member of Sigma Xi Honor Society.

RELATED Practices

Intellectual Property

Covering all major areas of Intellectual Property law with the focus of a boutique and the backing of a large firm. We partner with clients ranging in size from large […]

Learn more about our Intellectual Property Department

1 of 1


Selected Speaking Engagements
  • Presenter, “Understanding the Implications of Bilski on the Diagnostics Business Models,” 2009 BioNetwork, October 2009
  • Presenter, “In re Fisher: Utility Requirements,” 22nd Annual Joint Seminar Program, May 2006
Selected Publications
  • Author, “Merck v. Integra Lifesciences I., Ltd.: Uncertainty in the Scope of the Section 271(e) (1) Exemption,” The Intellectual Property Strategist, August 2005
  • Author, Exp. Parasitol. 80(2):328-332
  • Author, Gene 151(1-2):335-336
  • Author, J. Clin. Invest. 94(1):413-417
  • Author, Trans. Am. Microsc. Soc. 109:107-110
Professional Activities
  • Consultant, U.S. Department of State, BioIndustry Initiative Program
Community Involvement
  • Former Adjunct Professor, Temple University James E. Beasley School of Law
  • Former Adjunct Professor, Licensing Executives Society (LES)
  • Volunteer, Disability Resources and Services

Law School

  • Temple University James E. Beasley School of Law

Graduate School

  • Hahnemann University|University of Pennsylvania

Undergraduate School

  • Hamilton College